The progressive emergence of the ERα and ERα-regulated genes (e.g., progesterone receptor, PS2, TMPRSS2-ERG fusion and NEAT1) during PCa progression and hormone refractory disease suggests that these tumors can bypass the AR by using estrogens and progestins for their growth. This evidence concerns the gene ESR1 and posterior cortical atrophy.